SNO 2020: TKIs Hold Promise in Oncogene-Driven NSCLC With Symptomatic CNS Metastases
The agents have demonstrated a remarkable intracranial activity.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.